Insider Transactions in Q3 2024 at Inhibrx Biosciences, Inc. (INXB)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 16
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
13,037
+1.81%
|
$221,629
$17.13 P/Share
|
Sep 12
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
26,963
+3.75%
|
$404,445
$15.05 P/Share
|
Sep 11
2024
|
Kristiina Md Vuori Director |
BUY
Open market or private purchase
|
Direct |
6,457
+31.91%
|
$96,855
$15.07 P/Share
|
Sep 10
2024
|
Kristiina Md Vuori Director |
BUY
Open market or private purchase
|
Direct |
179
+2.39%
|
$2,685
$15.0 P/Share
|
Sep 10
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
8,500
+1.26%
|
$127,500
$15.19 P/Share
|
Sep 09
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
9,500
+1.43%
|
$142,500
$15.21 P/Share
|
Sep 06
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
26,000
+3.86%
|
$390,000
$15.29 P/Share
|
Sep 03
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
20,000
+5.74%
|
$300,000
$15.99 P/Share
|
Aug 30
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
10,000
+6.45%
|
$140,000
$14.02 P/Share
|
Aug 29
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
10,000
+6.9%
|
$140,000
$14.03 P/Share
|
Aug 29
2024
|
Kristiina Md Vuori Director |
BUY
Open market or private purchase
|
Direct |
7,140
+50.0%
|
$99,960
$14.0 P/Share
|
Aug 28
2024
|
Kimberly Manhard Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$130,000
$13.98 P/Share
|
Aug 23
2024
|
Douglas Forsyth Director |
BUY
Open market or private purchase
|
Indirect |
59,812
+21.03%
|
$837,368
$14.07 P/Share
|
Aug 22
2024
|
Douglas Forsyth Director |
BUY
Open market or private purchase
|
Indirect |
15,188
+8.44%
|
$182,256
$12.89 P/Share
|
Aug 21
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
12,945
+19.09%
|
$155,340
$12.93 P/Share
|
Aug 20
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
27,055
+39.22%
|
$324,660
$12.97 P/Share
|